Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Investor Day (2017)
8 slides from Coloplast A/s Class B's investor day presentation, 2017
Slide 1: Finance and Global Operations
Finance and Global Operations Coloplast Meet the Management London 2017 Anders Lonning Skovgaard, EVP & CFO Allan Rasmussen, EVP Global Operations
Slide 2: EBIT margin improvement is a function of scalability and continued cost discipline
FINANCE EBIT margin improvement is a function of scalability and continued cost discipline Future drivers of EBIT margin EBIT will be positively impacted by: + Leverage effect + Innovation Excellence – savings of DKK 80-100m by end 2017/18 + GOP4 + Utilisation of Business Centre in Poland +0.5-1.0%
Slide 3: We continue to invest in solid investment cases to lift growth and leverage effect
FINANCE We continue to invest in solid investment cases in order to lift our growth and leverage effect LEAD20 strategy has an investment capacity of up to DKK 2bn Innovation Consumer R&D 3-4% of sales • . Page 3
Slide 4: GOP plans have driven margin improvement; key programme in GOP3 was Innovation Excellence
GLOBAL OPERATIONS GOP plans have driven margin improvement and a key programme in our GOP3 plan was Innovation Excellence GOP plans have been successfully implemented GOP 3 finalized at the end of this year 1. Reduce risk of supply 2. Improve quality of daily Operational Excellence II disruption mat
Slide 5: Through Innovation Excellence we have strengthened pilot, ramp-up and R&D capabilities
GLOBAL OPERATIONS Through Innovation Excellence we have strengthened our pilot, ramp-up and R&D capabilities Pilot and ramp-up capabilities R&D capabilities Pilot organization Core R&D organization strengthened strengthened Enables reduced transfer time to volume production Enables faster ramp-up at
Slide 6: GOP4 plan will be launched next year and support innovation agenda and margin improvement
GLOBAL OPERATIONS GOP4 plan will be launched next year and support our innovation agenda and margin improvement ambition 2. Network optimisation 1. Risk reduction and stability in supply 3. Operating efficiency GOP4 6. Next level innovation 4. Advanced technology 5. Best country location Enablers: C
Slide 7: We continue to deliver attractive cash returns despite large investments
We continue to deliver attractive cash returns despite large investments in commercial and expansion activities Coloplast cash distribution to investors Dividends paid out in the year (DKKm)* Share buy-back (DKKm) Pay-out ratio (%)** 82 80 78 77 77 We will continue to return excess cash 38 to shareh
Slide 8: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast A/S - Ostomy Care / C